The Wall Street Journal Health Blog reports that many top people at Merck will keep their positions as the merger with Schering-Plough goes through. Merck's CEO, Dick Clark, will stay in charge. Also keeping their spots are Kenneth Frazier, the head of global human health, Peter Kim, the head of research labs, and Willie Deese, the head of manufacturing. Schering-Plough's Stanley Barshay will continue to run the consumer health division, but only on an interim basis.